# First in Human Study for the Assessment of Safety and Initial Performance of the EAS1 System

> **NCT06423690** · NA · RECRUITING · sponsor: **Snipe Medical** · enrollment: 15 (estimated)

## Conditions studied

- Lung Cancer

## Interventions

- **DEVICE:** EAS1 System

## Key facts

- **NCT ID:** NCT06423690
- **Lead sponsor:** Snipe Medical
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-11-01
- **Primary completion:** 2025-05-15
- **Final completion:** 2025-07-15
- **Target enrollment:** 15 (ESTIMATED)
- **Last updated:** 2024-12-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06423690

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06423690, "First in Human Study for the Assessment of Safety and Initial Performance of the EAS1 System". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT06423690. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
